Evidence map›Paper›PMID 39572647›Full record

ArticleScientific reports2024

Digital continuous glucose monitoring systems for patients with HIV-diabetes comorbidity in Ethiopia: a situational analysis.

Tsegahun Manyazewal, Mohammed K Ali, Tedla Kebede, Samrawit Solomon, Damen Hailemariam, Shivani A Patel, Cam Escoffery, Yimtubezinash Woldeamanuel, Francesco Marinucci, Michele Joseph and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tsegahun ManyazewalCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. tsegahun.manyazewal@aau.edu.et.
Mohammed K AliHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Tedla KebedeSchool of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Samrawit SolomonSchool of Public Health, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Damen HailemariamSchool of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Shivani A PatelHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Cam EscofferyDepartment of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Yimtubezinash WoldeamanuelCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Francesco MarinucciInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Michele JosephCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Tewodros GetinetSchool of Public Health, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Wondwossen AmogneCollege of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Abebaw FekaduCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Vincent C MarconiEmory University School of Medicine and Rollins School of Public Health, Atlanta, GA, USA.

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
COllaborative research, implementation, And LEadership training to addresS chronic Conditions across the lifecoursE (COALESCE)D43TW011404 · FIC · EMORY UNIVERSITY · PI ALI, MOHAMMED KUMAIL, HAILEMARIAM, DAMEN · 2019 to 2023
$1.2M
Emory Center for AIDS Research P30AI050409FIC NIH HHS D43 TW011404NIAID NIH HHS P30 AI050409NIH HHS D43TW011404
6 · The paper itself

Abstract

In patients with HIV-diabetes mellitus (DM) comorbidity, invasive blood glucose testing can increase the risk of HIV-related blood contamination and discourage regular glucose monitoring. Digital continuous glucose monitoring (CGM) systems may allow real-time glucose monitoring without the need for blood specimens. However, in high-burden HIV-DM countries, current glucose monitoring practices and their challenges are insufficiently explored to guide digital CGM research and developments. This study sought to explore the lived experiences of patients with HIV-DM comorbidity and their healthcare providers regarding glucose monitoring practices, and their openness to CGM and other digital technologies, to provide formative insights for a planned implementation trial of digital CGM in Ethiopia. A phenomenological qualitative study was conducted among patients with HIV-DM and their providers at the two largest public hospitals in Ethiopia. Both groups were interviewed face-to-face about DM clinic workflows, blood glucose monitoring and self-testing practices, and potential benefits and limitations of digital CGM systems. Interviews were audio-recorded, transcribed verbatim, and analyzed thematically. A total of 37 participants were interviewed, consisting of 18 patients with HIV-DM comorbidity and 19 healthcare providers. Patients had an average (min-max) duration of living with HIV and DM of 14 (8-31) and 6.6 (1-16) years, respectively, with 61% taking insulin-33% alone and 28% alongside oral hypoglycemic agents-and 79% having comorbid hypertension. The thematic analysis identified five main themes: "Diabetes routine clinical care and follow-up", "Blood glucose monitoring practices", "Perceptions about digital CGMs", "Technology adoption", and "Financial coverage". Home self-testing was deemed beneficial, but the need for regular follow-ups, result cross-referencing, and glucometer reliability were emphasized. Patients performed fingerstick themselves or with family members, expressing concerns about waste disposal and the risk of HIV transmission. They rely mainly on health insurance for DM care. Patients and providers are happy with the quality of DM services but note a lack of integrated HIV-DM care. Very few providers and patients possessed background information about digital CGMs, and all have not yet utilized them in practice, but expressed keen interest in trying them, representing an important step for upcoming CGM clinical trials in these settings. Given the crucial role of regular glucose testing in managing HIV-DM comorbidity, it is essential to explore testing options that align with patient preferences and minimize the risk of HIV transmission.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes MellitusHIV InfectionsAdultComorbidityContinuous Glucose MonitoringEthiopiaFemaleHumansMaleMiddle AgedQualitative ResearchBlood GlucoseBlood glucoseContinuous glucose monitoringDiabetes mellitusDigital healthEthiopiaHIV

Identifiers

PMID39572647
PMCPMC11582811

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.